Transapical aortic valve implantation in patients with pre-existing mitral valve prostheses: a case report

Table 1 Preoperative demographics

	Patient 1	Patient 2
Age [y]	76	74
Sex	Male	Male
EOA [cm²]	0.4	0.7
EOAI [cm²/m²]	0.21	0.32
Pre-op ΔP_mean [mmHg]	83	35
LVEF [%]	61	65
NYHA-class	III	III
NTproBNP [pg/ml]	1086	2461
CCS	I	II
CABG	No	Yes
MVR	Mechanical Valve (Carbomedics, 27 mm)	Biological Valve (Perimount Plus, 27 mm)
Chronic atrial fibrillation	Yes	Yes
COPD [GOLD]	IV	III
PHT	Moderate	Severe
PAD [Fontaine]	II	II
EuroSCORE I [%]	32.83	55.56
EuroSCORE II [%]	11.61	11.08
STS-score, PROM [%]	5.52	6.72

(CABG coronary artery bypass grafting, CCS Canadian Cardiovascular Society, COPD chronic obstructive pulmonary disease, EOA effective orifice area, EOAI effective orifice area index, EuroSCORE European System for Cardiac Operative Risk Evaluation, LVEF left ventricular ejection fraction, MVR Mitral valve replacement, NYHA New York Heart Association, PAD peripheral arterial disease-fontaine classification, PHT pulmonary hypertension, Pre-Op Δp_mean preoperative mean transaortic pressure gradient, STS-score, PROM Society of Thoracic Surgeons-score, predictive risk of mortality, y years)

ISSN: 1749-8090